Kidney metastases.
Renal cell carcinoma is not common malignancy. Unfortunately, it remains difficult to cure, with small improvements being made in chemo/immunotherapeutic areas. Surgery remains the most successful approach for curative treatment in both primary and metastatic disease. Prospective studies are critically needed to definitively determine appropriate prognostic indicators for operation.
Dresler
C M
CM
Section of Thoracic Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy; D011379:Prognosis; D011446:Prospective Studies; D015996:Survival Rate
D000970:Antineoplastic Agents